network meta-analysis
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
-
ADHD, amphetamines, atomoxetine, bupropion, clonidine, dexmethylphenidate, guanfacine, medication, medication safety, medicines, meta-analysis, methylphenidate, modafinil, network meta-analysis, neurodiversity, pharmacological intervention, psychopharmacology, Stimulants, systematic review, The Lancet Psychiatry, therapeutic inertia, viloxazineThe Goldilocks zone: getting ADHD medication ‘just right’
Neurodivergence, including Attention Deficit-Hyperactivity Disorder (ADHD), remains an area of great interest…
-
aerobic exercise, Anxiety, Brain, cancer survivorship, cancer-related fatigue, depression, exercise oncology, mind-body exercise, network meta-analysis, Psychology, resistance trainingExercise for Cancer Fatigue: Yoga Leads, Aerobic Training Improves QoL
A 2026 network meta-analysis of 57 randomized trials involving 5,675 cancer survivors…
-
exenatide, GLP-1, lixisenatide, network meta-analysis, Neurodegenerative Diseases, neurology, neuroprotection, neuroscience, Ozempic, parkinson’s diseaseCan GLP-1 Drugs Slow Parkinson’s Disease? Evidence from 5 Trials
Research Highlights GLP-1 receptor agonists are diabetes drugs (Ozempic, Trulicity, Byetta) being…
